Cue Biopharma, Inc. (CUE) vs Electra Therapeutics Inc. (ETRA)

A side-by-side comparison of Cue Biopharma, Inc. and Electra Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CUE

Cue Biopharma, Inc.

$177M

$24.36HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

ETRA

Electra Therapeutics Inc.

$207M

$9.74HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — CUE vs ETRA

growth of $100 · dividends reinvested · last 1y

CUE -28.7% (-28.7%/yr)ETRA -26.5% (-26.5%/yr)ETRA compounded faster over this window

CUE ETRA

Metrics side by side

Total return (annualized)

Metric	CUE	ETRA
Total return (1Y)	11.33%	N/A
Total return CAGR (3Y)	-28.59%	N/A
Total return CAGR (5Y)	-42.42%	N/A

ETRA is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full CUE analysis Full ETRA analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.